Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance)
Year: 2013
Type: article
Source: Blood
Authors: Anjali S. Advani, Ben Sanford, Selina Luger, Meenakshi Devidas, Eric C. Larsen, Michaela Liedtke, Peter M Voorhees, Matthew C. Foster, David F. Claxton, Susan Geyer, Edy Parker, Kristin Coffan, William L. Carroll, Naomi J. Winick, Steven E. Coutre, Martin S Tallman, Frederick R. Appelbaum, Harry Paul Erba, Richard M. Stone, Stephen P. Hunger, Richard A. Larson, Wendy Stock
Institutions: Cleveland Clinic, Duke Medical Center, Abramson Cancer Center, University of Pennsylvania, University of Florida Health, University of Florida, Stanford University, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Penn State Cancer Institute, Alliance for Clinical Trials in Oncology, New York University, The University of Texas Southwestern Medical Center, Memorial Sloan Kettering Cancer Center, Fred Hutch Cancer Center, University of Alabama at Birmingham, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Children's Hospital Colorado, University of Colorado Anschutz, University of Chicago
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W203547899